tiprankstipranks
Trending News
More News >
AEON Biopharma (AEON)
:AEON
US Market
Advertisement

AEON Biopharma (AEON) Income Statement

Compare
220 Followers

AEON Biopharma Income Statement

Last quarter (Q3 2025), AEON Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, AEON Biopharma's net income was $-4.54M. See AEON Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 2.52M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 2.52M
Operating Expenses
$ -72.98M$ 348.09M$ 48.43M$ 65.85M$ 18.91M
Depreciation and Amortization
$ 97.00K$ 99.00K$ 68.00K$ 3.00K$ 875.00K
EBITDA
$ -27.73M$ -52.74M$ -48.36M$ -36.88M$ -15.51M
Operating Income
$ 72.98M$ -348.09M$ -48.43M$ -65.85M$ -16.39M
Other Income/Expenses
$ -30.98M$ -36.55M$ -4.13M$ 10.21M$ -16.52M
Pretax Income
$ 42.01M$ -384.63M$ -52.56M$ -55.64M$ -32.91M
Net Income
$ 42.01M$ -384.63M$ -52.56M$ -55.64M$ -32.91M
Per Share Metrics
Basic EPS
$ 77.74$ -4.99$ -27.25$ -31.73$ -547.60
Diluted EPS
$ 72.93$ -4.99$ -27.25$ -31.73$ -547.60
Weighted Average Shares Outstanding
575.00K 77.07M 1.93M 1.75M 60.00K
Weighted Average Shares Outstanding (Diluted)
575.95K 77.07M 1.93M 1.75M 91.62K
Currency in USD

AEON Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis